Pfizer Ousts Moderna as Day Traders’ Favorite Vaccine Maker

Bloomberg2021-08-19

Move over Moderna Inc., Pfizer Inc. is the new day traders’ favorite Covid-19 vaccine stock. Pfizer climbed about 9% in the the four trading days through Tuesday, with retail traders snapping up about...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

stephh
2021-08-19
stephh
Like and comment. Thanks.
- Oldie:
  done likewise

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113170668?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-08-19 10:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113170668","market":"us","top_or_hot":-1,"title":"Pfizer Ousts Moderna as Day Traders’ Favorite Vaccine Maker","media":"Bloomberg","content":"<div>\n<p>Move over Moderna Inc., Pfizer Inc. is the new day traders’ favorite Covid-19 vaccine stock.\nPfizer climbed about 9% in the the four trading days through Tuesday, with retail traders snapping up about...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-18/pfizer-ousts-moderna-as-day-trader-s-favorite-vaccine-maker?srnd=markets-vp\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Ousts Moderna as Day Traders’ Favorite Vaccine Maker</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Ousts Moderna as Day Traders’ Favorite Vaccine Maker\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-19 10:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-08-18/pfizer-ousts-moderna-as-day-trader-s-favorite-vaccine-maker?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Move over Moderna Inc., Pfizer Inc. is the new day traders’ favorite Covid-19 vaccine stock.\nPfizer climbed about 9% in the the four trading days through Tuesday, with retail traders snapping up about...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-18/pfizer-ousts-moderna-as-day-trader-s-favorite-vaccine-maker?srnd=markets-vp\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-08-18/pfizer-ousts-moderna-as-day-trader-s-favorite-vaccine-maker?srnd=markets-vp","article_id":"1113170668","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113170668","pubTimestamp":1629340449,"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Move over Moderna Inc., Pfizer Inc. is the new day traders’ favorite Covid-19 vaccine stock.\nPfizer ","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"translate_title":"辉瑞取代莫德纳成为日内交易者最喜欢的疫苗制造商","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9,"PFE":0.9},"content_text":"Move over Moderna Inc., Pfizer Inc. is the new day traders’ favorite Covid-19 vaccine stock.\nPfizer climbed about 9% in the the four trading days through Tuesday, with retail traders snapping up about $63 million of the shares on Tuesday alone, according to data from Vanda Research. The day-trading crowd sold off more positions than they bought in Moderna and BioNTech.\nIt marks a sharp change in fortunes. Both Moderna and BioNTech have amassed triple digit gains this year, a rally the nearly $280 billion-valued Pfizer missed out on with a scant 34% gain, despite being the first -- along with BioNTech -- to win authorization for a Covid shot in the U.S. The U.S. announced today that it would start offering booster shots to the already vaccinated in September.\nAs Pfizer rallies, BioNTech has tumbled more than 18% from a record high reached on Aug. 9, while Moderna is down roughly 18% from its zenith. All three stocks slumped today, with Pfizer reversing early gains to close down 2.2%.\n\nPfizer’s stock now trades at about an 8% premium to the average analyst price target, compared to more than 30% for Moderna and 18% for BioNTech.\nThe recent closing of the gap may not spell the end of the rally. Wall Street is already adjusting its models with Pfizer getting a new Wall Street high price target of $61 from Cantor Fitzgerald analyst Louise Chen on Tuesday.\nThe drugmaker’s “pipeline advancements and product sales continue to exceed our expectations,” she wrote in a note to clients.","kind":null,"is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":831483443,"gmtCreate":1629340732482,"gmtModify":1676530008433,"author":{"id":"3575058137963235","authorId":"3575058137963235","name":"stephh","avatar":"https://static.tigerbbs.com/7e248aeda9d24c835ab13541550241cf","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":4,"crmLevelSwitch":0,"idStr":"3575058137963235","authorIdStr":"3575058137963235"},"htmlText":"Like and comment. Thanks.&nbsp;","listText":"Like and comment. Thanks.&nbsp;","text":"Like and comment. Thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/831483443","repostId":1113170668,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5574988,"gmtCreate":1629342328487,"gmtModify":1663232592848,"authorId":3584415246670106,"author":{"id":3584415246670106,"idStr":"3584415246670106","authorId":3584415246670106,"name":"Oldie","avatar":"https://static.tigerbbs.com/09a7a0c9fe9b5b416d6f049746ddfa29","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":831483443,"type":1,"supId":0,"prevId":0,"content":"done likewise","text":"done likewise","html":"done likewise"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":47,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113170668"}